IN:MAXHEALTHCARE
Max Healthcare
- Stock
Last Close
990.15
22/11 10:00
Market Cap
872.15B
Beta: -
Volume Today
1.90M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 208.80M - | 231.70M 10.97% | 256.95M 10.90% | 271.40M 5.62% | 346.90M 27.82% | 485.85M 40.05% | 575.80M 18.51% | 687.95M 19.48% | |||
average payables | 1.86B - | 2.15B 15.72% | 2.39B 11.12% | 2.78B 16.27% | 2.93B 5.13% | 3.65B 24.63% | 4.44B 21.74% | 4.98B 12.14% | |||
average receivables | 2.13B - | 4.28B 101.16% | 3.91B 8.64% | ||||||||
book value per share | 0.33 - | 20.67 - | 20.27 1.97% | 18.95 6.51% | 17.65 6.85% | 21.78 23.41% | 65.32 199.91% | 64.94 0.59% | 76.41 17.67% | ||
capex per share | -1.25 - | -29.42 - | -2.11 92.84% | -1.20 43.02% | -2.12 76.58% | -1.96 7.70% | -1.37 29.92% | -5.80 322.91% | -3.46 40.35% | ||
capex to depreciation | -1.00 - | -17.60 - | -1.07 93.93% | -0.67 37.04% | -1.13 67.55% | -0.74 34.27% | -0.68 8.22% | -2.54 273.18% | -1.45 43.06% | ||
capex to operating cash flow | -0.70 - | -2.22 - | -0.74 66.84% | -0.80 8.15% | -1.30 63.24% | -0.36 72.70% | -1.00 182.86% | -0.75 25.36% | -0.28 62.99% | ||
capex to revenue | -0.05 - | -1.28 - | -0.08 93.74% | -0.04 52.13% | -0.07 80.83% | -0.05 31.16% | -0.05 0.08% | -0.14 203.01% | -0.07 49.11% | ||
cash per share | 0.40 - | 0.18 - | 0.37 104.55% | 1.65 344.30% | 0.21 87.06% | 6.19 2,803.86% | 7.26 17.23% | 5.03 30.76% | 15.45 207.38% | ||
days of inventory on hand | 10.29 - | 21.26 - | 19.95 6.17% | 22.96 15.12% | 25.98 13.14% | 40.41 55.54% | 33.04 18.24% | 24.27 26.54% | 30.18 24.35% | ||
days payables outstanding | 93.83 - | 198.71 - | 184.37 7.21% | 215.20 16.72% | 291.22 35.32% | 273.46 6.10% | 267.54 2.16% | 178.79 33.17% | 215.14 20.33% | ||
days sales outstanding | 62.63 - | 40.51 35.33% | 28.15 30.50% | ||||||||
debt to assets | 0.26 - | 0.28 6.86% | 0.26 6.14% | 0.28 5.36% | 0.29 6.12% | 0.30 0.95% | 0.40 33.13% | 0.16 60.84% | 0.12 20.53% | 0.07 44.67% | |
debt to equity | 24.77 - | 0.48 98.04% | 0.71 46.77% | 0.79 11.09% | 0.95 19.79% | 1.04 9.81% | 1.53 47.57% | 0.24 84.68% | 0.18 23.29% | 0.09 48.43% | |
dividend yield | |||||||||||
earnings yield | -0.01 - | -0.00 - | 0.00 140.03% | -0.00 417.46% | -0.00 99.34% | 0.02 60,504.49% | -0.01 134.26% | 0.02 379.03% | 0.03 43.41% | ||
enterprise value | 45.80B - | 3.96B 91.35% | 68.93B 1,639.80% | 69.57B 0.93% | 70.68B 1.59% | 70.92B 0.34% | 63.06B 11.08% | 184.59B 192.71% | 344.57B 86.67% | 434.19B 26.01% | |
enterprise value over ebitda | 161.73 - | 51.34 - | 33.40 34.95% | 43.50 30.26% | 34.09 21.63% | 17.71 48.07% | 33.31 88.12% | 32.16 3.45% | 31.47 2.15% | ||
ev to operating cash flow | 62.54 - | 9.54 - | 44.58 367.23% | 85.96 92.82% | 79.73 7.24% | 25.24 68.34% | 156.62 520.45% | 46.04 70.61% | 35.91 22.00% | ||
ev to sales | 4.85 - | 5.48 - | 4.84 11.79% | 4.13 14.65% | 4.24 2.75% | 3.39 20.17% | 7.44 119.52% | 8.87 19.33% | 9.52 7.24% | ||
free cash flow per share | 0.53 - | -16.18 - | 0.75 104.65% | 0.31 59.34% | -0.49 260.46% | 3.55 824.07% | -0.01 100.18% | 1.93 29,922.59% | 9.01 365.63% | ||
free cash flow yield | 0.00 - | -0.14 - | 0.01 104.65% | 0.00 59.34% | -0.00 260.46% | 0.03 824.07% | -0.00 100.10% | 0.01 17,749.93% | 0.02 266.98% | ||
graham net net | -17.19 - | -34.73 - | -36.82 6.03% | -40.01 8.65% | -43.57 8.91% | -55.91 28.31% | -22.39 59.95% | -21.36 4.60% | -9.19 56.95% | ||
graham number | 3.42 - | 13.88 - | 8.70 37.36% | 14.98 72.28% | 1.18 92.15% | 32.10 2,630.24% | 44.15 37.54% | 95.59 116.49% | 139.88 46.33% | ||
income quality | -1.13 - | -38.11 - | 33.21 187.14% | -5.41 116.29% | 10.69 297.62% | 2.80 73.77% | -1.72 161.22% | 1.01 159.00% | 1.14 12.22% | ||
intangibles to total assets | 0.04 - | 0.03 12.43% | 0.43 1,297.78% | 0.41 4.37% | 0.38 6.76% | 0.37 2.43% | 0.32 13.27% | 0.56 73.25% | 0.56 0.76% | 0.50 9.83% | |
interest coverage | 0.54 - | 0.67 - | 1.06 58.18% | 0.71 32.53% | 1.10 53.81% | 1.61 46.66% | 2.22 38.32% | 9.45 325.02% | 13.68 44.86% | ||
interest debt per share | 7.14 - | 15.89 - | 17.77 11.80% | 19.61 10.40% | 20.11 2.55% | 36.66 82.29% | 17.33 52.72% | 12.64 27.09% | 7.97 36.94% | ||
inventory turnover | 35.47 - | 17.17 - | 18.30 6.58% | 15.90 13.14% | 14.05 11.61% | 9.03 35.71% | 11.05 22.31% | 15.04 36.13% | 12.10 19.58% | ||
invested capital | 24.77 - | 0.48 98.04% | 0.71 46.77% | 0.79 11.09% | 0.95 19.79% | 1.04 9.81% | 1.53 47.57% | 0.24 84.68% | 0.18 23.29% | 0.09 48.43% | |
market cap | 45.96B - | 60.98B - | 60.98B 0% | 60.98B 0% | 60.98B 0% | 50.66B 16.93% | 177.60B 250.58% | 336.34B 89.38% | 427.73B 27.17% | ||
net current asset value | -4.98B - | -2.36B 52.61% | -16.26B 589.06% | -16.93B 4.07% | -18.55B 9.61% | -19.55B 5.38% | -20.69B 5.81% | -17.81B 13.89% | -19.06B 7.02% | -7.49B 60.70% | |
net debt to ebitda | -0.57 - | 5.92 - | 4.12 30.36% | 5.97 44.78% | 4.78 19.96% | 3.48 27.11% | 1.26 63.79% | 0.77 39.03% | 0.47 39.07% | ||
net income per share | -1.57 - | -0.41 - | 0.17 140.03% | -0.53 417.46% | -0.00 99.34% | 2.10 60,504.49% | -1.33 163.07% | 6.25 571.48% | 11.38 81.96% | ||
operating cash flow per share | 1.78 - | 13.24 - | 2.86 78.40% | 1.51 47.31% | 1.63 8.17% | 5.51 238.09% | 1.37 75.22% | 7.74 466.62% | 12.47 61.18% | ||
payables turnover | 3.89 - | 1.84 - | 1.98 7.78% | 1.70 14.33% | 1.25 26.10% | 1.33 6.50% | 1.36 2.21% | 2.04 49.63% | 1.70 16.89% | ||
receivables turnover | 5.83 - | 9.01 54.63% | 12.97 43.88% | ||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -0.05 - | -0.01 - | 0.00 137.50% | -0.01 387.33% | -0.00 99.36% | 0.04 41,029.76% | -0.03 182.73% | 0.15 586.62% | 0.22 47.70% | ||
revenue per share | 22.96 - | 23.03 - | 26.35 14.41% | 31.36 19.03% | 30.63 2.35% | 41.07 34.08% | 28.76 29.97% | 40.14 39.57% | 47.05 17.23% | ||
roe | -4.76 - | -0.02 - | 0.01 140.83% | -0.03 439.55% | -0.00 99.29% | 0.10 49,048.12% | -0.02 121.03% | 0.10 574.28% | 0.15 54.64% | ||
roic | -0.07 - | 0.03 - | 0.10 272.80% | 0.04 64.18% | -0.00 103.49% | 0.09 7,710.82% | 0.09 7.62% | 0.09 3.50% | 0.14 62.63% | ||
sales general and administrative to revenue | 0.30 - | 0.29 4.39% | 0.26 9.79% | 0.27 4.44% | 0.26 2.98% | 0.23 11.18% | 0.23 0.46% | 0.22 7.57% | |||
shareholders equity per share | 0.33 - | 20.67 - | 20.27 1.97% | 18.95 6.51% | 17.65 6.85% | 21.78 23.41% | 65.32 199.91% | 64.94 0.59% | 76.41 17.67% | ||
stock based compensation to revenue | 0.00 - | 0.00 - | 0.00 89.78% | 0.01 - | 0.01 18.18% | 0.01 13.84% | |||||
tangible asset value | 5.04B - | 8.17B 62.10% | -1.77B 121.67% | -1.84B 4.04% | -2.36B 27.83% | -2.92B 23.97% | -2.50B 14.50% | 8.50B 440.55% | 11.72B 37.85% | 23.44B 99.99% | |
tangible book value per share | 12.26 - | -3.25 - | -3.38 4.04% | -4.32 27.83% | -5.35 23.97% | -5.51 2.92% | 9.85 278.85% | 12.11 22.99% | 24.17 99.53% | ||
working capital | -723.80M - | 1.08B 249.31% | -1.32B 221.82% | -338.30M 74.30% | -443.50M 31.10% | -6.93B 1,461.96% | -7.06B 1.93% | 3.48B 149.22% | 2.43B 30.07% | 8.97B 269.31% |
All numbers in (except ratios and percentages)